Pangenomic Health Inc.
Canadian Securities ExchangeTotal Valuation
Pangenomic Health Inc. carries a market capitalization of 4.64M, placing it among publicly traded companies globally.
| Market Cap | 4.64M |
| Enterprise Value | N/A |
Share Statistics
Pangenomic Health Inc. currently has 25.70M shares outstanding.
| Shares Outstanding | 25.70M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
| PE Ratio | N/A |
| PS Ratio | N/A |
| PB Ratio | -0.66 |
| P/TBV Ratio | -2.57 |
| P/FCF Ratio | -2.99 |
| P/OCF Ratio | -2.99 |
Financial Position
Pangenomic Health Inc. maintains a current ratio of 0.07, meaning it holds 0.1x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 0.07 |
| Quick Ratio | 0.02 |
| Debt / Equity | N/A |
| Debt / EBITDA | N/A |
| Interest Coverage | -830.68 |
Financial Efficiency
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -3,430.24 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Stock Price Statistics
Pangenomic Health Inc.'s stock has declined approximately -17.5% over the past 52 weeks. The 50-day moving average sits at 0.43, while the 200-day moving average is 0.90.
| Beta (5Y) | N/A |
| 52-Week Price Change | -17.5% |
| 50-Day Moving Average | 0.43 |
| 200-Day Moving Average | 0.90 |
| Average Volume (20 Days) | N/A |
Income Statement
EBITDA reached -3.40M, while operating income came in at -3.40M.
| Revenue | N/A |
| Gross Profit | N/A |
| Operating Income | -3.40M |
| Pretax Income | -3.43M |
| Net Income | -3.43M |
| EBITDA | -3.40M |
| EBIT | -3.40M |
| Earnings Per Share (EPS) | -0.28 |
Balance Sheet
Total book value stands at -8.53M, with working capital of -2.19M providing operational flexibility.
| Cash & Cash Equivalents | 38,766.00 |
| Total Debt | N/A |
| Net Debt | 174,108.00 |
| Equity (Book Value) | -8.53M |
| Book Value Per Share | -0.70 |
| Working Capital | -2.19M |
Cash Flow
Pangenomic Health Inc. produced -1.88M in operating cash flow over the past twelve months.
| Operating Cash Flow | -1.88M |
| Capital Expenditures | N/A |
| Free Cash Flow | -1.88M |
| FCF Per Share | -0.15 |
Dividends & Yields
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | -34.06 |
| FCF Yield | -33.39 |
Stock Splits
Pangenomic Health Inc.'s most recent stock split took place on November 28, 2024 with a 5:1 split ratio.
| Last Split Date | 11/28/2024 |
| Split Ratio | 5:1 |
Scores
Pangenomic Health Inc. posts an Altman Z-Score of -303.82, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -303.82 |